🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This pilot phase II trial studies how well giving brentuximab vedotin, comb...
Status
Active Not Recruiting
Location
Lucile Packard Children's Hospital Stanford University
Start Date
2013-08-12
Trial ID
NCT01920932
RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Status
Unknown
Location
Universitair Medisch Centrum St. Radboud - Nijmegen
Start Date
2006-10
Trial ID
NCT00433433
Treatments Being Tested
This is a multicenter randomized trial evaluating induction treatment with ...
Status
Completed
Location
Dr REMY GRESSIN
Start Date
1995-01
Trial ID
NCT00970385
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of pembrol...
Status
Completed
Location
St Joseph Heritage Healthcare-Oncology ( Site 0004)
Start Date
2021-10-07
Trial ID
NCT05008224
1. To observe and compare the overall response rate (ORR) of baseline BEACO...
Status
Unknown
Location
Multiple Locations
Start Date
2016-06
Trial ID
NCT02800447
This study will examine the safety and efficacy of pembrolizumab (MK-3475) ...
Status
Active Not Recruiting
Location
Children's Hospital of Alabama ( Site 0023)
Start Date
2018-04-09
Trial ID
NCT03407144
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Status
Completed
Location
Mobile Infirmary Medical Center
Start Date
1999-06-17
Trial ID
NCT00003389
This is a phase II study using risk and response-adapted therapy for low, i...
Status
Active Not Recruiting
Location
Lucile Packard Children's Hospital Stanford University
Start Date
2018-12-12
Trial ID
NCT03755804
Reduction of the indication for radiotherapy (RT) in newly diagnosed patien...
Status
Recruiting
Location
Schneider children's medical center
Start Date
2015-11
Trial ID
NCT02797717
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as doxorubicin hydrochloride, b...
Status
Terminated
Location
Stanford Cancer Center
Start Date
2013-05-24
Trial ID
NCT01390584